4.7 Article

Structural basis of thalidomide enantiomer binding to cereblon

期刊

SCIENTIFIC REPORTS
卷 8, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41598-018-19202-7

关键词

-

资金

  1. Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan
  2. Uehara Memorial Foundation, Japan
  3. Ministry of Education, Culture, Sports, Science and Technology (MEXT) [23102002]
  4. PRESTO, JST [JPMJPR1531]
  5. MEXT [17H06112, 17H04213, 26750374]
  6. Grants-in-Aid for Scientific Research [15H04288, 17H06112, 26750374, 26251006, 23102002, 17H04213] Funding Source: KAKEN

向作者/读者索取更多资源

Thalidomide possesses two optical isomers which have been reported to exhibit different pharmacological and toxicological activities. However, the precise mechanism by which the two isomers exert their different activities remains poorly understood. Here, we present structural and biochemical studies of (S)- and (R)-enantiomers bound to the primary target of thalidomide, cereblon (CRBN). Our biochemical studies employed deuterium-substituted thalidomides to suppress optical isomer conversion, and established that the (S)-enantiomer exhibited similar to 10-fold stronger binding to CRBN and inhibition of self-ubiquitylation compared to the (R)-enantiomer. The crystal structures of the thalidomide-binding domain of CRBN bound to each enantiomer show that both enantiomers bind the tri-Trp pocket, although the bound form of the (S)-enantiomer exhibited a more relaxed glutarimide ring conformation. The (S)-enantiomer induced greater teratogenic effects on fins of zebrafish compared to the (R)-enantiomer. This study has established a mechanism by which thalidomide exerts its effects in a stereospecific manner at the atomic level.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据